Recursion, Novavax and Crispr Therapeutics slip in premarket trading after surging Wednesday on posi

RXRX, SDGR, RLAY and ABSI are using AI-powered platforms to transform drug discovery while advancing

Recursion Pharmaceuticals (NASDAQ: RXRX) is using artificial intelligence to generate and analyze bi

Recursion Pharmaceuticals NASDAQ: RXRX is using artificial intelligence to generate and analyze biol

Cramer likes Vistra and Constellation, but not NextEra. Recursion and Fastly reported weak earnings,

California State Teachers Retirement System lifted its holdings in Recursion Pharmaceuticals, Inc. (

Recursion Pharmaceuticals, Inc. (RXRX) Presents at Bank of America SMID Cap Virtual Conference Trans

Anthropic is preparing what could be the largest IPO of 2026, and it's telling investors the pitch g

Recursion Pharmaceuticals, Inc. remains a Hold as competitive advances and slow revenue growth chall

Recursion misses Q2 earnings and revenue estimates as collaboration revenues fall year over year, se

Recursion Pharmaceuticals NASDAQ: RXRX outlined progress across its clinical pipeline, drug-discover

Recursion Pharmaceuticals, Inc. (RXRX) Q2 2026 Earnings Call Transcript

Recursion Pharmaceuticals (RXRX) came out with a quarterly loss of $0.25 per share versus the Zacks

Recursion Pharmaceuticals (NASDAQ:RXRX) reported quarterly losses of $(0.25) per share which missed

Genentech advanced the collaboration's first neuroscience target into a joint early discovery progra

Salt Lake City, UT, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical-s

Salt Lake City, UT, July 31, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical s

Analysts remain optimistic that the market will view upcoming catalysts in a bullish light.

The latest trading day saw Recursion Pharmaceuticals (RXRX) settling at $2.97, representing a -2.62%

Salt Lake City, UT, July 29, 2026 (GLOBE NEWSWIRE) -- Salt Lake City, UT, July 29, 2026 (GLOBE NEWSW

In the closing of the recent trading day, Recursion Pharmaceuticals (RXRX) stood at $3.01, denoting

A Small AI Company Just Took the Stage at One of the Biggest Events in Computing, and It Points to W

Amova Asset Management Americas Inc. decreased its position in shares of Recursion Pharmaceuticals,

Anthropic launches Claude Science for researchers as PwC data shows AI mentions in pharma M&A de

Morgan Stanley analyst Vikram Purohit maintains Recursion Pharmaceuticals (NASDAQ:RXRX) with a Eq

Recursion Pharmaceuticals to update on FDA trial design for REC-4881 for FAP in the second half of 2

Needham analyst Gil Blum reiterates Recursion Pharmaceuticals (NASDAQ:RXRX) with a Buy and mainta

Recursion Pharmaceuticals (NASDAQ:RXRX) reported quarterly losses of $(0.22) per share which beat th

JP Morgan analyst Priyanka Grover maintains Recursion Pharmaceuticals (NASDAQ:RXRX) with a Overwe

Citeline, a leader in clinical solutions for the life sciences industry, today announced an expanded

B of A Securities analyst Michael Ryskin maintains Recursion Pharmaceuticals (NASDAQ:RXRX) with a

Needham analyst Gil Blum reiterates Recursion Pharmaceuticals (NASDAQ:RXRX) with a Buy and mainta

Shares of Recursion Pharmaceuticals (NASDAQ: RXRX) are surging Wednesday following a robust earnings

ARK's 2025 winners included Robinhood, AMD and Palantir, while its losers were The Trade Desk, R

Here's a look at the earnings calendar for the week ahead, including reports from Nvidia, Joby,

Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares are under pressure Wednesday after new regulatory

Wall Street ends 2026 positively with tech stocks dominating, but concerns over valuations drive int

Cathie Wood-led Ark Invest executed several significant trades on Wednesday, with notable activity i

Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares moved higher Wednesday after JPMorgan upgraded th

JP Morgan analyst Eric Joseph upgrades Recursion Pharmaceuticals (NASDAQ:RXRX) from Neutral to Ov

Shares of Recursion Pharmaceuticals are trading higher Monday after the company reported positive da